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tion, 1450
Risk of cardiovascular disease in relation to
achieved office and ambulatory blood pressure
control in treated hypertensive subjects, 878
Role of genotyping in risk factor assessment for
sudden death in hypertrophic cardiomyopathy
(editorial), 2049
Soluble intercellular adhesion molecule-1 and long-
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computed tomography versus cardiac magnetic
resonance imaging for the assessment of left
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Deconditioning fails to explain peripheral skeletal
muscle alterations in men with chronic heart
failure, 1170
Reduction of insulin-like growth factor-1
expression in the skeletal muscle of
noncachectic patients with chronic heart
failure, 1175
Smoking
Contribution of nicotine to acute endothelial
dysfunction in long-term smokers, 251
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